1620 Investment Advisors’s Medtronic MDT Stock Holding History
Bought
Maintained
Sold
Other funds holding MDT
LMFP
FWIA
SRIM
DC
CAI
VF
1620 Investment Advisors's MDT Position: Q2 2026 in Review
1620 Investment Advisors increased its Medtronic (MDT) stake by 3.2% in Q2 2026, buying an estimated $18.6K and bringing the position to 7,464 shares worth $584K. The position accounts for 0.36% of the portfolio, ranked #75.
1620 Investment Advisors first reported a position in MDT in Q1 2024 and has held it in 10 quarters since. The position peaked at $1.19M in Q4 2025. 673 funds tracked by Wall St. Rank hold MDT as of Q2 2026.
- 1620 Investment Advisors held 7,464 shares of Medtronic worth $584K as of Q2 2026.
- 1620 Investment Advisors bought 230 Medtronic shares in Q2 2026, an estimated $18.6K.
- Medtronic made up 0.36% of 1620 Investment Advisors's portfolio in Q2 2026, its #75 holding.
- 1620 Investment Advisors first reported a position in Medtronic in Q1 2024 and has held it in 10 quarters since.
- 1620 Investment Advisors's Medtronic position peaked at $1.19M in Q4 2025.
- 673 funds tracked by Wall St. Rank held Medtronic as of Q2 2026.
Based on 1620 Investment Advisors's 13F filing for Q2 2026, filed 14 Jul 2026.